Optimization of Conservative Therapy Approaches for Benign Prostatic Hyperplasia with 5-Alpha Reductase Inhibitors: A Clinical and Morphological Study
January 2012
in “
Курский научно-практический вестник "Человек и его здоровье"
”
TLDR 5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.
The study aimed to enhance the understanding of clinical and pathological processes in the prostate and improve therapeutic outcomes for patients with benign prostatic hyperplasia using 5-alpha-reductase inhibitors, such as finasteride and herbal drugs. It involved 65 patients with prostatic hyperplasia. Based on the clinical and morphological changes observed in these patients, the study developed indications for monotherapy with 5-alpha-reductase inhibitors.